Cargando…

Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging

BACKGROUND: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-penetrating ability. For all such features, NIR QDs have great p...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Jlenia, Riolo, Giulia, Gentile, Mariangela, Bernini, Andrea, Paccagnini, Eugenio, Falciani, Chiara, Lozzi, Luisa, Scali, Silvia, Depau, Lorenzo, Pini, Alessandro, Lupetti, Pietro, Bracci, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834876/
https://www.ncbi.nlm.nih.gov/pubmed/29501065
http://dx.doi.org/10.1186/s12951-018-0346-1
Descripción
Sumario:BACKGROUND: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-penetrating ability. For all such features, NIR QDs have great potential for early cancer diagnosis, in vivo tumor imaging and high resolution electron microscopy studies on cancer cells. RESULTS: In the present study we constructed NIR QDs functionalized with the NT4 cancer-selective tetrabranched peptides (NT4-QDs). We observed specific uptake of NT4-QDs in human cancer cells in in vitro experiments and a much higher selective accumulation and retention of targeted QDs at the tumor site, compared to not targeted QDs, in a colon cancer mouse model. CONCLUSIONS: NIR QDs labelled with the tetrabranched NT4 peptide have very promising performance for selective addressing of tumor cells in vitro and in vivo, proving rising features of NT4-QDs as theranostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12951-018-0346-1) contains supplementary material, which is available to authorized users.